The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Screening for colorectal cancer using the faecal occult blood test, Hemoccult
Open accessAbstract
BACKGROUND: Colorectal cancer is a leading cause of morbidity and mortality, especially in the Western world. The human and financial costs of this disease have prompted considerable research efforts to evaluate the ability of screening tests to detect the cancer at an early curable stage. Tests that have been considered for population screening include variants of the faecal occult blood test, flexible sigmoidoscopy and colonoscopy. Reducing mortality from colorectal cancer (CRC) may be achieved by the introduction of population-based screening programmes. OBJECTIVES: To determine whether screening for colorectal cancer using the faecal occult blood test (guaiac or immunochemical) reduces colorectal cancer mortality and to consider the benefits, harms and potential consequences of screening. SEARCH STRATEGY: Published and unpublished data for this review were identified by: Reviewing studies included in the previous Cochrane review; Searching several electronic databases (Cochrane Library, Medline, Embase, CINAHL, PsychInfo, Amed, SIGLE, HMIC); and Writing to the principal investigators of potentially eligible trials. SELECTION CRITERIA: We included in this review all randomised trials of screening for colorectal cancer that compared faecal occult blood test (guaiac or immunochemical) on more than one occasion with no screening and reported colorectal cancer mortality. DATA COLLECTION AND ANALYSIS: Data from the eligible trials were independently extracted by two reviewers. The primary data analysis was performed using the group participants were originally randomised to ('intention to screen'), whether or not they attended screening; a secondary analysis adjusted for non-attendence. We calculated the relative risks and risk differences for each trial, and then overall, using fixed and random effects models (including testing for heterogeneity of effects). We identified nine articles concerning four randomised controlled trials and two controlled trials involving over 320,000 participants with follow-up ranging from 8 to 18 years. MAIN RESULTS: Combined results from the 4 eligible randomised controlled trials shows that participants allocated to screening had a 16% reduction in the relative risk of colorectal cancer mortality (RR 0.84, CI: 0.78-0.90). In the 3 studies that used biennial screening (Funen, Minnesota, Nottingham) there was a 15% relative risk reduction (RR 0.85, CI: 0.78-0.92) in colorectal cancer mortality. When adjusted for screening attendance in the individual studies, there was a 25% relative risk reduction (RR 0.75, CI: 0.66 - 0.84) for those attending at least one round of screening using the faecal occult blood test. AUTHORS' CONCLUSIONS: Benefits of screening include a modest reduction in colorectal cancer mortality, a possible reduction in cancer incidence through the detection and removal of colorectal adenomas, and potentially, the less invasive surgery that earlier treatment of colorectal cancers may involve. Harmful effects of screening include the psycho-social consequences of receiving a false-positive result, the potentially significant complications of colonoscopy or a false-negative result, the possibility of overdiagnosis (leading to unnecessary investigations or treatment) and the complications associated with treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,793
Randomised study of screening for colorectal cancer with faecal-occult-blood test
Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D., & Søndergaard, O. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03430-7 · Cited by 2,501
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,623
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
Mandel, J. S., Church, T. R., Bond, J. H., Ederer, F., Geisser, M. S., Mongin, S. J., Snover, D. C., & Schuman, L. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432203 · Cited by 1,423
Weitz, J., Koch, M., Debus, J., Höhler, T., Galle, P. R., & Büchler, M. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17706-x · Cited by 1,098
Bernie, T., Les, I., Paul, G., Jan, K., David, W., & Chris, S. (1998) · BMJ · doi:10.1136/bmj.317.7158.559 · Cited by 811
Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood
Mandel, J. S., Church, T. R., Ederer, F., & Bond, J. H. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.434 · Cited by 788
van Rossum, L. G., van Rijn, A. F., Laheij, R. J., van Oijen, M. G., Fockens, P., van Krieken, H. H., Verbeek, A. L., Jansen, J. B., & Dekker, E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.040 · Cited by 734
Citarda, F., Tomaselli, G., Capocaccia, R., Barcherini, S., Crespi, M., & Group, T. I. M. S. (2001) · Gut · doi:10.1136/gut.48.6.812 · Cited by 716
A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening
Allison, J. E., Tekawa, I. S., Ransom, L. J., & Adrain, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340304 · Cited by 622
RANDOMISED, CONTROLLED TRIAL OF FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCER
Hardcastle, J. D., Chamberlain, J., Sheffield, J., Balfour, T. W., Armitage, N. C., Thomas, W. M., Pye, G., James, P. D., Amar, S. S., & Moss, S. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92750-5 · Cited by 529
Hol, L., van Leerdam, M. E., van Ballegooijen, M., van Vuuren, A. J., van Dekken, H., Reijerink, J. C. I. Y., van der Togt, A. C. M., Habbema, J. D. F., & Kuipers, E. J. (2010) · Gut · doi:10.1136/gut.2009.177089 · Cited by 481
Faivre, J., Dancourt, V., Lejeune, C., Tazi, M. A., Lamour, J., Gerard, D., Dassonville, F., & Bonithon-Kopp, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.018 · Cited by 460
Jørgensen, O. D., Kronborg, O., & Fenger, C. (2002) · Gut · doi:10.1136/gut.50.1.29 · Cited by 392
An evidence based approach to individualising treatment
Glasziou, P. P., & Irwig, L. M. (1995) · BMJ · doi:10.1136/bmj.311.7016.1356 · Cited by 391
Self-citationAll-Cause Mortality in Randomized Trials of Cancer Screening
Black, W. C. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.167 · Cited by 390
Screening for Colorectal Cancer With Fecal Occult Blood Testing and Sigmoidoscopy
Winawer, S. J., Flehinger, B. J., Schottenfeld, D., & Miller, D. G. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.16.1311 · Cited by 381
Cancer Risk in Relatives of Patients with Common Colorectal Cancer
St. John, D. J. B., McDermott, F. T., Hopper, J. L., Debney, E. A., Johnson, W. R., & Hughes, E. S. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00005 · Cited by 368
Hoff, G., Grotmol, T., Skovlund, E., Bretthauer, M., & for the Norwegian Colorectal Cancer Prevention Study Group (2009) · BMJ · doi:10.1136/bmj.b1846 · Cited by 311
Lindholm, E., Brevinge, H., & Haglind, E. (2008) · British Journal of Surgery · doi:10.1002/bjs.6136 · Cited by 298
Scholefield, J. H., Moss, S., Sufi, F., Mangham, C. M., & Hardcastle, J. D. (2002) · Gut · doi:10.1136/gut.50.6.840 · Cited by 291
Hol, L., Wilschut, J. A., van Ballegooijen, M., van Vuuren, A. J., van der Valk, H., Reijerink, J. C. I. Y., van der Togt, A. C. M., Kuipers, E. J., Habbema, J. D. F., & van Leerdam, M. E. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604961 · Cited by 269
Kronborg, O., Jørgensen, O. D., Fenger, C., & Rasmussen, M. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410003182 · Cited by 262
Kewenter, J., Brevinge, H., Engarás, B., Haglind, E., & Ährén, C. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409096840 · Cited by 249
Effect of Fecal Occult Blood Testing on Mortality from Colorectal Cancer: A Case–Control Study
Selby, J. V., Friedman, G. D., Quesenberry, Jr., & Weiss, N. S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-1-199301010-00001 · Cited by 230
Segnan, N., Senore, C., Andreoni, B., Arrigoni, A., Bisanti, L., Cardelli, A., Castiglione, G., Crosta, C., DiPlacido, R., Ferrari, A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji050 · Cited by 194
Stewart-Brown, S., & Farmer, A. (1997) · BMJ · doi:10.1136/bmj.314.7080.533 · Cited by 188
Weissfeld, J. L., Schoen, R. E., Pinsky, P. F., Bresalier, R. S., Church, T., Yurgalevitch, S., Austin, J. H., Prorok, P. C., & Gohagan, J. K. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji175 · Cited by 181
Kronborg, O., Fenger, C., Olsen, J. H., Bech, K., & Søndergaard, O. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909093096 · Cited by 149
United States cancer statistics; 2004 incidence and mortality
Ajani, U. A. (2007) · Cited by 145
LANG, C. A. (1994) · JAMA · doi:10.1001/jama.271.13.1011 · Cited by 136
Hereditary nonpolyposis colorectal cancer
Lynch, H. T., & Lynch, J. F. (2000) · Seminars in Surgical Oncology · Cited by 124
The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps
Cappell, M. S. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.08.011 · Cited by 91
Fecal Occult Blood Screening in the Minnesota Study: Sensitivity of the Screening Test
Church, T. R., Mandel, J. S., & Ederer, F. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.19.1440 · Cited by 90
Federici, A., Rossi, P. G., Borgia, P., Bartolozzi, F., Farchi, S., & Gausticchi, G. (2005) · Journal of Medical Screening · doi:10.1258/0969141053908357 · Cited by 88
Castiglione, G., Zappa, M., Grazzini, G., Mazzotta, A., Biagini, M., Salvadori, P. A., & Ciatto, S. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.329 · Cited by 84
Lisi, D., Hassan, C., & Crespi, M. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.07.019 · Cited by 82
Senore, C., Armaroli, P., Silvani, M., Andreoni, B., Bisanti, L., Marai, L., Castiglione, G., Grazzini, G., Taddei, S., Gasperoni, S., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.583 · Cited by 76
Guittet, L., Bouvier, V., Mariotte, N., Vallée, J.-P., Levillain, R., Tichet, J., & Launoy, G. D. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604996 · Cited by 73
Participation in mass screening for colorectal cancer
Fuivrr, J., Arwux, P., Milm, C., et al. (1991) · European Journal of Cancer Prevention · doi:10.1097/00008469-199110000-00010 · Cited by 63
Endoscopic and surgical complications of work-up in screening for colorectal cancer
Kewenter, J., & Brevinge, H. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02056949 · Cited by 63
Meta-analysis adjusting for compliance: The example of screening for breast cancer
Glasziou, P. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90166-k · Cited by 60
Self-citationFecal occult blood screening for colorectal cancer
Dam, J. V. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.22.2389 · Cited by 53
Colorectal Cancer Mortality in Two Areas of Tuscany With Different Screening Exposures
Costantini, A. S., Martini, A., Puliti, D., Ciatto, S., Castiglione, G., Grazzini, G., & Zappa, M. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn404 · Cited by 29
Cited by
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., van de Velde, C. J. H., & Watanabe, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.65 · Cited by 1,563
Association of Colonoscopy and Death From Colorectal Cancer
Baxter, N. N., Goldwasser, M. A., Paszat, L. F., Saskin, R., Urbach, D. R., & Rabeneck, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00306 · Cited by 1,254
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Metadata
- Authors
- Hewitson, P., Glasziou, P. P., Irwig, L., Towler, B., & Watson, E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-01-24
- Volume
- 2011
- Issue
- 2
- Pages
- CD001216-CD001216
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2161920747
- Cited by
- 742
- References
- 47
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.